Drug

Who makes miglustat?

7 companies list miglustat as a human prescription drug, including under the names OPFOLDA, Zavesca, Yargesa. Forms: capsule. Routes: oral.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing miglustat

CompanyFormsApplicationNDCsRegistered sites
ANI Pharmaceuticals, Inc.United StatescapsuleANDAANDA20834211
Navinta LLCUnited StatescapsuleANDAANDA21911111
Zydus Pharmaceuticals USA Inc.IndiacapsuleANDAANDA21911111
Actelion Pharmaceuticals US, Inc.capsuleNDANDA02134810
Amicus Therapeutics US, LLCcapsuleNDANDA21521110
CoTherix, Inc.capsuleNDA AUTHORIZED GENERICNDA02134810
Edenbridge Pharmaceuticals LLC.capsuleANDAANDA20982110

Bulk ingredient listings

Orange Book patents

10 unexpired patents list miglustat as the active ingredient, expiring between Mar 2033 and Sept 2038. Application holder: AMICUS THERAPEUTICS US LLC.

Enquiry

Common questions

Who makes miglustat?
7 companies list miglustat as a human prescription drug in the openFDA NDC Directory, led by ANI Pharmaceuticals, Inc., Navinta LLC, Zydus Pharmaceuticals USA Inc., Actelion Pharmaceuticals US, Inc., Amicus Therapeutics US, LLC. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Is there a generic OPFOLDA?
4 companies list miglustat under an abbreviated new drug application (ANDA), the application type used for generics, and 2 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.
Who supplies miglustat active ingredient?
6 companies list miglustat as a bulk ingredient, including APOTHECON PHARMACEUTICALS PRIVATE LIMITED, Amino Chemicals Ltd., Apicore US LLC, Dipharma Francis Srl.